Thalidomide-Dexamethasone for Multiple Myeloma

Clinical trial NCT00038090 · COMPLETED

Trial details

NCT number: NCT00038090
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2000-06-01
Primary completion: 2005-05-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.